Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 2
1997 2
1998 1
2001 2
2004 1
2008 1
2009 1
2010 1
2019 5
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies.
Zurth C, Koskinen M, Fricke R, Prien O, Korjamo T, Graudenz K, Denner K, Bairlein M, von Bühler CJ, Wilkinson G, Gieschen H. Zurth C, et al. Among authors: gieschen h. Eur J Drug Metab Pharmacokinet. 2019 Dec;44(6):747-759. doi: 10.1007/s13318-019-00577-5. Eur J Drug Metab Pharmacokinet. 2019. PMID: 31571146 Free PMC article. Clinical Trial.
Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial.
Shore N, Zurth C, Fricke R, Gieschen H, Graudenz K, Koskinen M, Ploeger B, Moss J, Prien O, Borghesi G, Petrenciuc O, Tammela TL, Kuss I, Verholen F, Smith MR, Fizazi K. Shore N, et al. Among authors: gieschen h. Target Oncol. 2019 Oct;14(5):527-539. doi: 10.1007/s11523-019-00674-0. Target Oncol. 2019. PMID: 31571095 Free PMC article. Clinical Trial.
Untargeted metabolomic profiling of Sphagnum fallax reveals novel antimicrobial metabolites.
Fudyma JD, Lyon J, AminiTabrizi R, Gieschen H, Chu RK, Hoyt DW, Kyle JE, Toyoda J, Tolic N, Heyman HM, Hess NJ, Metz TO, Tfaily MM. Fudyma JD, et al. Among authors: gieschen h. Plant Direct. 2019 Nov 12;3(11):e00179. doi: 10.1002/pld3.179. eCollection 2019 Nov. Plant Direct. 2019. PMID: 31742243 Free PMC article.
In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development.
Zane P, Gieschen H, Kersten E, Mathias N, Ollier C, Johansson P, Van den Bergh A, Van Hemelryck S, Reichel A, Rotgeri A, Schäfer K, Müllertz A, Langguth P. Zane P, et al. Among authors: gieschen h. Eur J Pharm Biopharm. 2019 Sep;142:222-231. doi: 10.1016/j.ejpb.2019.06.010. Epub 2019 Jun 21. Eur J Pharm Biopharm. 2019. PMID: 31233862 Review.
Survival After Robotic-Assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study.
Wang Y, Gieschen H, Greenberger M, Yu X, Tian G, VanderWalde N, Stockstill T, Farmer M, Rinker L, Izaguirre EW, Somer B, Ballo MT. Wang Y, et al. Among authors: gieschen h. Ann Surg. 2019 Oct 28. doi: 10.1097/SLA.0000000000003637. Online ahead of print. Ann Surg. 2019. PMID: 31663972
Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats.
Taavitsainen P, Gieschen H, Korjamo T, Kähkönen M, Malmström C, Prien O, Niehues M, Sandmann S, Janssen W, Koskinen M. Taavitsainen P, et al. Among authors: gieschen h. Xenobiotica. 2020 Aug;50(8):967-979. doi: 10.1080/00498254.2020.1723038. Epub 2020 Feb 6. Xenobiotica. 2020. PMID: 32003293
Pharmacokinetics of Darolutamide, its Diastereomers and Active Metabolite in the Mouse: Response to Saini NK et al. (2020).
Nykänen P, Korjamo T, Gieschen H, Zurth C, Koskinen M. Nykänen P, et al. Among authors: gieschen h. Drug Metab Lett. 2020 Nov 12. doi: 10.2174/1872312814666201112121129. Online ahead of print. Drug Metab Lett. 2020. PMID: 33183216
The bioavailability of oral fludarabine phosphate is unaffected by food.
Oscier D, Orchard JA, Culligan D, Cunningham D, Johnson S, Parker A, Klein M, Gieschen H. Oscier D, et al. Among authors: gieschen h. Hematol J. 2001;2(5):316-21. doi: 10.1038/sj.thj.6200113. Hematol J. 2001. PMID: 11920267 Clinical Trial.
Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate.
Koitka M, Höchel J, Obst D, Rottmann A, Gieschen H, Borchert HH. Koitka M, et al. Among authors: gieschen h. Anal Biochem. 2008 Oct 1;381(1):113-22. doi: 10.1016/j.ab.2008.06.019. Epub 2008 Jun 18. Anal Biochem. 2008. PMID: 18602882
Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR. Hoffmann J, et al. Among authors: gieschen h. J Natl Cancer Inst. 2004 Feb 4;96(3):210-8. doi: 10.1093/jnci/djh022. J Natl Cancer Inst. 2004. PMID: 14759988
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback